Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN
· Real-Time Price · USD
4.32
-0.10 (-2.26%)
At close: Oct 16, 2025, 3:59 PM
4.20
-2.78%
After-hours: Oct 16, 2025, 07:46 PM EDT
-2.26% (1D)
| Bid | 4.11 |
| Market Cap | 46.65M |
| Revenue (ttm) | 100.65K |
| Net Income (ttm) | -19.25M |
| EPS (ttm) | -1.78 |
| PE Ratio (ttm) | -2.43 |
| Forward PE | -2.22 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 4.51 |
| Volume | 82,968 |
| Avg. Volume (20D) | 215,953 |
| Open | 4.45 |
| Previous Close | 4.42 |
| Day's Range | 4.21 - 4.52 |
| 52-Week Range | 2.55 - 6.12 |
| Beta | 1.57 |
| Ex-Dividend Date | n/a |
About LTRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LTRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LTRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-3.99%
Lantern Pharma shares are trading lower. The compa...
Unlock content with
Pro Subscription
2 months ago
+10.72%
Lantern Pharma shares are trading higher after the company announced early enrollment in Japan for lung cancer.
